Listen
Reason for request
Inclusion on the list of medicines refundable by National Heath Insurance and approved for hospital use.
-
Clinical Benefit
| Low |
The actual benefit of COMBODART is low when it is prescribed as a replacement for separate doses of tamsulosin and dutasteride, provided that this combination has been well tolerated during at least 6 months of treatment. |
| Insufficient |
The Committee considers that the actual benefit of COMBODART is insufficient as a first-line treatment or when prescribed following monotherapy with dutasteride or tamsulosin. |
Clinical Added Value
| no clinical added value |
COMBODART provides no improvement in actual benefit (IAB V) in the management ofbenign prostatic hyperplasia. |
Documents
English version
Contact Us
Évaluation des médicaments
